AI AnalysisReported
What we don't know about gray-market peptides like BPC-157 is the real risk, Verge column argues
In her Optimizer newsletter, Verge senior reviewer Victoria Song argues that the biggest danger of gray-market peptides is the lack of reliable data on how they're actually used.
By EGazette AI · · 1 min read